Kontour Medical released its 2026 interim report. Net profit attributable to the parent in the first half was 41.39 million yuan, down 24.7% year on year, while operating revenue was 171 million yuan, up 0.4% year on year. Second-quarter operating revenue was 97.28 million yuan, up 10.8% year on year, and net profit attributable to the parent was 28.23 million yuan, down 8.8% year on year. The company's neurosurgery business achieved operating revenue of 146 million yuan, down 2.26% year on year, of which PEEK material product revenue was 113 million yuan, up 4.06% year on year. Cardiothoracic surgery business revenue was 6.36 million yuan, down 45.86% year on year, affected by volume-based procurement and intensifying competition. Maxillofacial repair business revenue was 11.56 million yuan, up 128.23% year on year. As of the end of the second quarter, the company's total assets were 932 million yuan, up 2.5% from the end of the previous year, and net assets attributable to the parent were 746 million yuan, up 3.9%.
Kontour (Xi'an) Medical Technology Co. Ltd.First-half net profit attributable to parent fell 24.7% year on year to 41.39 million yuan, with revenue nearly flat.